Neuroscience
Multiple Sclerosis
100%
Neurofilament Light Chain
26%
Teriflunomide
21%
Blood Plasma
20%
Secondary Progressive Multiple Sclerosis
17%
Proteome
17%
Relapsing Remitting Multiple Sclerosis
16%
Magnetic Resonance Imaging
16%
Neurofilament
11%
Ocrelizumab
10%
Migration Inhibition Factor
10%
Expanded Disability Status Scale
9%
Serine Protease HTRA1
7%
Sarcoidosis
7%
Transcriptome
6%
Tamsulosin
6%
Cognitive Function
5%
Macrophage Migration Inhibition Factor
5%
Nerve Fiber
5%
Rituximab
5%
Brain Lesion
5%
Natalizumab
5%
MicroRNA
5%
Optic Neuritis
5%
Cognitive Disorders
5%
Meningitis
5%
Serine Protease
5%
Immunosuppression
5%
Neuromyelitis Optica
5%
Protein S100B
5%
Neuron-Specific Enolase
5%
Remyelinization
5%
Fingolimod
5%
Alemtuzumab
5%
Interleukin 8
5%
Hypertension
5%
Immunology and Microbiology
Multiple Sclerosis
68%
Cerebrospinal Fluid
32%
Fumaric Acid Dimethyl Ester
28%
Neurofilament
19%
Teriflunomide
16%
Light Chain
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Ocrelizumab
14%
Blood Plasma
11%
CD20
10%
Adoptive Immunity
10%
Blood Level
10%
Breakthrough Infection
8%
Lymphocytopenia
6%
Spike
6%
Macrophage Migration Inhibition Factor
5%
Migration Inhibition Factor
5%
Calcium Binding
5%
Neuromyelitis Optica
5%
Protein Binding
5%
Meningitis
5%
Neurosarcoidosis
5%
Secondary Progressive Multiple Sclerosis
5%
Remyelinization
5%
Tumor Necrosis Factor
5%
Humoral Immunity
5%
Medicine and Dentistry
Multiple Sclerosis
60%
Fumaric Acid Dimethyl Ester
32%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Cohort Analysis
16%
Messenger RNA
13%
Triage
10%
Outpatient
10%
Teriflunomide
10%
Cellular Immunity
10%
Infection
10%
CD20
10%
Ocrelizumab
9%
Neurofilament
8%
Adverse Event
7%
Lymphocytopenia
6%
Optical Coherence Tomography
6%
Cross Sectional Study
6%
Light Chain
5%
Natalizumab
5%
mRNA Vaccine
5%
Randomized Controlled Trial
5%
microRNA
5%
Symbol Digit Modalities Test
5%
Cerebral Atrophy
5%
Multiple Myeloma
5%
Optic Neuritis
5%
Progressive Multifocal Leukoencephalopathy
5%
Disease Course
5%
Humoral Immunity
5%
Ocular Sarcoidosis
5%
Sarcoidosis
5%
Neurosarcoidosis
5%
